Literature DB >> 33223215

NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues.

Kamran Mushtaq1, Muhammad Umair Khan2, Fatima Iqbal3, Deema Hussam Alsoub4, Hammad Shabir Chaudhry4, Fateen Ata4, Phool Iqbal4, Khaled Elfert5, Girisha Balaraju5, Muna Almaslamani6, Khalid Al-Ejji5, Saad AlKaabi5, Yasser Medhat Kamel5.   

Abstract

Entities:  

Keywords:  COVID-19; Fatty liver; Liver injury; MAFLD; Mortality; NAFLD

Year:  2020        PMID： 33223215     DOI： 10.1016/j.jhep.2020.09.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  15 in total

1.  Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.

Authors:  Thomas Marjot; Christiane S Eberhardt; Tobias Boettler; Luca S Belli; Marina Berenguer; Maria Buti; Rajiv Jalan; Mario U Mondelli; Richard Moreau; Daniel Shouval; Thomas Berg; Markus Cornberg
Journal:  J Hepatol       Date:  2022-07-20       Impact factor: 30.083

2.  Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity.

Authors:  Rosa Lombardi; Vincenzo La Mura; Annalisa Cespiati; Federica Iuculano; Giordano Sigon; Giada Pallini; Marco Proietti; Irene Motta; Beatrice Montinaro; Elisa Fiorelli; Matteo Cesari; Alessandra Bandera; Luca Valenti; Flora Peyvandi; Nicola Montano; Marina Baldini; Anna Ludovica Fracanzani
Journal:  Intern Emerg Med       Date:  2022-06-26       Impact factor: 5.472

3.  Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19.

Authors:  Jiuling Li; Aowen Tian; Haoxue Zhu; Lanlan Chen; Jianping Wen; Wanqing Liu; Peng Chen
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-03       Impact factor: 13.576

Review 4.  Coronavirus Disease-2019 (COVID-19) and the Liver.

Authors:  Anshuman Elhence; Manas Vaishnav; Sagnik Biswas; Ashish Chauhan; Abhinav Anand
Journal:  J Clin Transl Hepatol       Date:  2021-03-22

5.  Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19.

Authors:  Dafeng Liu; Yongli Zheng; Jun Kang; Dongmei Wang; Lang Bai; Yi Mao; Guifang Zha; Hong Tang; Renqing Zhang
Journal:  Front Med (Lausanne)       Date:  2022-01-07

6.  Liver Injury and Elevated FIB-4 Define a High-Risk Group in Patients with COVID-19.

Authors:  Dana Crisan; Lucretia Avram; Cristiana Grapa; Alexandra Dragan; Dan Radulescu; Sorin Crisan; Alin Grosu; Valentin Militaru; Elena Buzdugan; Laurentiu Stoicescu; Liliana Radulescu; Felix Ciovicescu; Delia Bunea Jivanescu; Oana Mocan; Bogdan Micu; Valer Donca; Luminita Marinescu; Antonia Macarie; Marina Rosu; Andrada Nemes; Rares Craciun
Journal:  J Clin Med       Date:  2021-12-28       Impact factor: 4.241

7.  Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study.

Authors:  Nina Vrsaljko; Lara Samadan; Klaudija Viskovic; Armin Mehmedović; Jelena Budimir; Adriana Vince; Neven Papic
Journal:  Open Forum Infect Dis       Date:  2022-02-09       Impact factor: 3.835

Review 8.  COVID-19 in normal, diseased and transplanted liver.

Authors:  Alessandro Signorello; Ilaria Lenci; Martina Milana; Giuseppe Grassi; Leonardo Baiocchi
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

Review 9.  COVID-19 impact on the liver.

Authors:  Liliana Baroiu; Caterina Dumitru; Alina Iancu; Ana-Cristina Leșe; Miruna Drăgănescu; Nicușor Baroiu; Lucreția Anghel
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

Review 10.  Liver injury in COVID-19: Detection, pathogenesis, and treatment.

Authors:  Yue Cai; Li-Ping Ye; Ya-Qi Song; Xin-Li Mao; Li Wang; Yan-Zhi Jiang; Wei-Tao Que; Shao-Wei Li
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.